Recently, the Ministry of Health in Israel approved the marketing of an Israel-developed colonoscopy device, which consists of three cameras and wide angle photography, three times what previously existed. This will result in more than 71% precise testing and quality for early detections and diagnoses of colorectal cancer. The endoscope, called Fuse
™, from the company EndoChoice, involved an international collaborative effort from both Israel and Germany. The new colonoscopy device will be installed for the first time in the next two weeks in an Israeli hospital, Elisha, and has already sparked interest in other hospitals. The company anticipates that the device will also be implemented in other gastroenterology screening areas in the coming year.
Colon cancer is common in Israel, the second-most prevalent cancer after breast cancer. Every year 3,200 patients are diagnosed with colorectal cancer and more than 1,800 die from it. On average, nine people are diagnosed with it everyday and five people die from the disease. This technology will prove extremely useful in detecting the cancer at an earlier stage, and will benefit both Israel and the world at large.
Below is the link to the article and a video describing the technology:
1) http://www.ynet.co.il/articles/0,7340,L-4472073,00.html
2) https://www.youtube.com/watch?v=Y58iPsZl9as
 |
The Fuse™ Endoscope Device.
http://www.endochoice.com/img/fuse_main_1C-1G_2013.12.jpg |
No comments:
Post a Comment